ActiveOTA

Generative Unconstrained Intelligence Drug Engineering (GUIDE) collaboration between U.S. interagency, academic and industry partners

DEPT OF THE ARMYDEPT OF DEFENSE.DEPT OF THE ARMY.AMC.ACC.ACC-CTRS.ACC-APG.W6QK ACC-APG

AI Overview

GUIDE collaborative platform integrating AI/ML simulation with experimental research to accelerate medical countermeasure development for warfighter protection.

This summary is AI-generated from the official solicitation.

Key Details

Agency
DEPT OF THE ARMY
Funding Amount
Release Date
December 1, 2025
Due Date
October 18, 2028

Official Description

W911SR-25-S-GUIDE Notice Type: Special Announcement Synopsis: This is a solicitation for parties interested in participating in projects sought by the The Joint Project Lead Chemical, Biological, Radiological, and Nuclear Defense Enabling Biotechnologies (JPL-CBRND-EB) (JPL EB). JPL EB has the mission to accelerate the delivery of medical countermeasures to the warfighter through the development and implementation of platform systems. Generative Unconstrained Intelligence Drug Engineering (GUIDE...

View on official source

Change History

Opportunity AddedApr 7, 2026 at 12:20 AM

Generative Unconstrained Intelligence Drug Engineering (GUIDE) collaboration between U.S. interagency, academic and industry partners

New SAM.gov opportunity: Generative Unconstrained Intelligence Drug Engineering (GUIDE) collaboration between U.S. interagency, academic and industry partners

Similar Opportunities

Get Alerts for Opportunities Like This

RallyProp monitors thousands of funding sources and sends instant alerts when opportunities match your technology and capabilities.

Start Free Trial